Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5426
WisdomTree True Emerging Markets Fund
XC
$80.4M
| $2.16M | ﹤0.01% |
70,354
-6,927
| -9% | -$222K |
|
5427
HDFC Bank
HDB
$119B
| $2.16M | ﹤0.01% |
67,722
-91,608
| -57% | -$2.93M |
|
5428
Hope Bancorp
HOPE
$1.83B
| $2.16M | ﹤0.01% |
175,852
-92,537
| -34% | -$1.2M |
|
|
PHYD
5429
DELISTED
Putnam ESG High Yield ETF
PHYD
| $2.16M | ﹤0.01% |
42,219
+29,603
| +235% | +$1.53M |
|
5430
CALL
Adient
ADNT
$1.54B
| $2.16M | ﹤0.01% |
125,400
+119,500
| +2,025% | +$2.39M |
|
5431
CALL
Jazz Pharmaceuticals
JAZZ
$16B
| $2.16M | ﹤0.01% |
17,500
-13,100
| -43% | -$1.54M |
|
5432
AB Core Plus Bond ETF
CPLS
$211M
| $2.15M | ﹤0.01% |
61,865
+28,490
| +85% | +$1.01M |
|
5433
Definitive Healthcare
DH
$67.7M
| $2.15M | ﹤0.01% |
524,091
-35,734
| -6% | -$156K |
|
|
HDV
5434
iShares Core High Dividend ETF
HDV
$15B
| $2.15M | ﹤0.01% |
95,815
+24,070
| +34% | +$566K |
|
5435
1st Source
SRCE
$2.12B
| $2.15M | ﹤0.01% |
36,842
+31,541
| +595% | +$1.95M |
|
5436
Xtrackers S&P 500 ESG ETF
SNPE
$2.97B
| $2.15M | ﹤0.01% |
40,369
-2,540
| -6% | -$137K |
|
5437
Dime Commercial Bancshares
DCOM
$1.81B
| $2.15M | ﹤0.01% |
69,951
+3,281
| +5% | +$106K |
|
|
BASE
5438
PUT
DELISTED
Couchbase
BASE
| $2.15M | ﹤0.01% |
137,900
+23,100
| +20% | +$394K |
|
5439
Peoples Bancorp
PEBO
$1.48B
| $2.15M | ﹤0.01% |
67,817
-23,640
| -26% | -$776K |
|
|
NLOP
5440
CALL
Net Lease Office Properties
NLOP
$171M
| $2.15M | ﹤0.01% |
68,746
-26,702
| -28% | -$830K |
|
|
FNGA
5441
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $2.14M | ﹤0.01% |
3,675
-11,606
| -76% | -$5.95M |
|
5442
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.14B
| $2.14M | ﹤0.01% |
22,285
-89,437
| -80% | -$8.81M |
|
5443
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.71B
| $2.14M | ﹤0.01% |
130,812
+61,103
| +88% | +$1.01M |
|
5444
State Street SPDR S&P Dividend ETF
SDY
$21.9B
| $2.14M | ﹤0.01% |
16,210
+9,134
| +129% | +$1.28M |
|
5445
U-Haul Holding Co
UHAL
$14.4B
| $2.14M | ﹤0.01% |
+30,977
| New | +$2.25M |
|
5446
CALL
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$602M
| $2.14M | ﹤0.01% |
37,300
+1,000
| +3% | +$53.8K |
|
5447
PUT
Direxion Daily AMZN Bull 2X ETF
AMZU
$282M
| $2.14M | ﹤0.01% |
50,900
+3,900
| +8% | +$149K |
|
5448
PUT
AMN Healthcare
AMN
$1.32B
| $2.14M | ﹤0.01% |
89,400
+25,100
| +39% | +$797K |
|
5449
CALL
Protolabs
PRLB
$2.15B
| $2.14M | ﹤0.01% |
54,700
+20,300
| +59% | +$730K |
|
5450
First Trust Small Cap Growth AlphaDEX Fund
FYC
$1.43B
| $2.14M | ﹤0.01% |
+27,579
| New | +$2.17M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.